Pro-oncogene FBI-1 inhibits the ferroptosis of prostate carcinoma PC-3 cells via the microRNA-324-3p/GPX4 axis

Mingsheng Liu1, Chenxiang Xu1, Hua Yang2

  • 1Second Ward of Urology, Qujing Affiliated Hospital of Kunming Medical University, Qujing City 655000, Yunnan Province, People's Republic of China.

Journal of Cancer
|July 1, 2024
PubMed

Insights

Factor that binds to inducer of short transcripts-1 (FBI-1) inhibits ferroptosis in prostate cancer by regulating the miR-324-3p/glutathione peroxidase 4 (GPX4) axis. This finding offers a new therapeutic target for endocrine-independent prostate carcinoma.

Area of Science:

  • Oncology
  • Cell Death Mechanisms
  • Molecular Biology

Background:

  • Ferroptosis, a non-apoptotic programmed cell death, presents a novel antitumor strategy.
  • The proto-oncogene FBI-1 is implicated in malignancies and therapy resistance.
  • The role of FBI-1 in endocrine-independent prostate carcinoma ferroptosis remains unelucidated.

Purpose of the Study:

  • To investigate the role of FBI-1 in ferroptosis of endocrine-independent prostate carcinoma.
  • To elucidate the molecular mechanisms underlying FBI-1-mediated ferroptosis.
  • To identify potential therapeutic targets for prostate cancer treatment.

Main Methods:

  • Utilized PC-3 cell line, a model for endocrine-independent prostate carcinoma.
  • Investigated the expression levels of FBI-1, miR-324-3p, and GPX4.
  • Employed overexpression and knockdown techniques for FBI-1.
  • Analyzed the regulatory relationship between FBI-1, miR-324-3p, and GPX4.
  • Examined clinical specimens for correlation analysis.

Main Results:

  • FBI-1 overexpression inhibited ferroptosis by increasing GPX4 levels.
  • FBI-1 knockdown induced ferroptosis by decreasing GPX4 levels.
  • miR-324-3p targets GPX4, leading to ferroptosis.
  • FBI-1 represses miR-324-3p expression via SP1 inhibition.
  • Clinical data showed positive correlation between FBI-1 and GPX4, and negative correlation between FBI-1 and miR-324-3p.

Conclusions:

  • FBI-1 inhibits ferroptosis in prostate carcinoma PC-3 cells through the miR-324-3p/GPX4 axis.
  • FBI-1 upregulates GPX4 by downregulating miR-324-3p, thereby suppressing ferroptosis.
  • The FBI-1/miR-324-3p/GPX4 pathway represents a potential therapeutic target for endocrine-independent prostate carcinoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K